| 12/08/22 | 07:00:04 | 12 Aug 2022 | | Statement: Zantac (ranitidine) litigation |
| 11/08/22 | 11:51:04 | 11 Aug 2022 | | Director/PDMR Shareholding |
| 10/08/22 | 16:57:10 | 10 Aug 2022 | | Director/PDMR Shareholding |
| 01/08/22 | 18:10:39 | 1 Aug 2022 | | Total Voting Rights |
| 01/08/22 | 13:43:15 | 1 Aug 2022 | | Director/PDMR Shareholding |
| 29/07/22 | 14:00:05 | 29 Jul 2022 | | Director/PDMR Shareholding |
| 29/07/22 | 10:00:05 | 29 Jul 2022 | | GSK Board change |
| 28/07/22 | 13:01:16 | 28 Jul 2022 | | Director/PDMR Shareholding |
| 27/07/22 | 07:00:12 | 27 Jul 2022 | | 2nd Quarter Results |
| 26/07/22 | 17:35:03 | 26 Jul 2022 | | Holding(s) in Company |
| 22/07/22 | 16:45:27 | 22 Jul 2022 | | Holding(s) in Company |
| 22/07/22 | 16:17:40 | 22 Jul 2022 | | Board and Committee Changes |
| 19/07/22 | 07:00:04 | 19 Jul 2022 | | Completion of GSK Share Consolidation |
| 18/07/22 | 18:00:05 | 18 Jul 2022 | | Holding(s) in Company |
| 18/07/22 | 07:00:07 | 18 Jul 2022 | | Haleon demerger completion and share consolidation |
| 12/07/22 | 09:48:01 | 12 Jul 2022 | | Director/PDMR Shareholding |
| 11/07/22 | 17:30:04 | 11 Jul 2022 | | GSK |
| 08/07/22 | 18:04:23 | 8 Jul 2022 | | Director/PDMR Shareholding |
| 08/07/22 | 17:30:20 | 8 Jul 2022 | | Director/PDMR Shareholding |
| 08/07/22 | 15:53:19 | 8 Jul 2022 | | Director/PDMR Shareholding |
| 08/07/22 | 15:33:23 | 8 Jul 2022 | | Director/PDMR Shareholding |
| 08/07/22 | 15:10:36 | 8 Jul 2022 | | Director/PDMR Shareholding |
| 06/07/22 | 16:30:05 | 6 Jul 2022 | | Result of General Meeting |
| 06/07/22 | 10:11:52 | 6 Jul 2022 | | Director/PDMR Shareholding |
| 05/07/22 | 12:43:53 | 5 Jul 2022 | | GSK disclose discontinued operations from Q2 2022 |
| 05/07/22 | 09:45:20 | 5 Jul 2022 | | Director/PDMR Shareholding |
| 05/07/22 | 09:30:18 | 5 Jul 2022 | | Director/PDMR Shareholding |
| 01/07/22 | 15:27:07 | 1 Jul 2022 | | Total Voting Rights |
| 01/07/22 | 14:45:55 | 1 Jul 2022 | | GSK completes acquisition of Sierra Oncology |
| 28/06/22 | 17:56:43 | 28 Jun 2022 | | Director/PDMR Shareholding |
| 28/06/22 | 07:00:07 | 28 Jun 2022 | | GSK files Shingrix 18+ at risk indication in Japan |
| 27/06/22 | 16:08:13 | 27 Jun 2022 | | Director/PDMR Shareholding |
| 24/06/22 | 15:44:50 | 24 Jun 2022 | | Director/PDMR Shareholding |
| 16/06/22 | 10:58:21 | 16 Jun 2022 | | Director/PDMR Shareholding |
| 10/06/22 | 07:00:08 | 10 Jun 2022 | | Positive phase III data for GSK’s RSV OA vaccine |
| 09/06/22 | 16:28:40 | 9 Jun 2022 | | Director/PDMR Shareholding |
| 07/06/22 | 17:17:08 | 7 Jun 2022 | | Director/PDMR Shareholding |
| 06/06/22 | 07:00:09 | 6 Jun 2022 | | US FDA approval of Priorix |
| 01/06/22 | 16:55:33 | 1 Jun 2022 | | Total Voting Rights |
| 01/06/22 | 13:00:02 | 1 Jun 2022 | | Demerger update: Publication of Documents |
| 01/06/22 | 07:00:10 | 1 Jun 2022 | | Demerger update: Submission of Documents to FCA |
| 31/05/22 | 07:00:05 | 31 May 2022 | | GSK to acquire Affinivax, Inc. |
| 30/05/22 | 10:00:02 | 30 May 2022 | | Further appointments to Designate Haleon Board |
| 27/05/22 | 07:00:02 | 27 May 2022 | | GSK Cervarix two-dose schedule approved by NMPA |
| 23/05/22 | 15:21:33 | 23 May 2022 | | Director/PDMR Shareholding |
| 19/05/22 | 10:02:29 | 19 May 2022 | | Iain Mackay - External Appointment |
| 16/05/22 | 14:00:03 | 16 May 2022 | | Change of name to GSK plc |
| 13/05/22 | 17:13:23 | 13 May 2022 | | Director/PDMR Shareholding |
| 12/05/22 | 08:58:18 | 12 May 2022 | | Director/PDMR Shareholding |
| 11/05/22 | 17:17:19 | 11 May 2022 | | Block listing Interim Review |
